Anthony P. Zook - 01 Mar 2026 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role: Chief Executive Officer, Director
Signature: /s/ Ali Olivo, Attorney-in-Fact
Issuer symbol: NEO
Transactions as of: 01 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 03 Mar 2026, 18:15:47 UTC
Previous filing: 10 Sep 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Zook Anthony P.	Chief Executive Officer, Director	9490 NEOGENOMICS WAY, FORT MYERS	/s/ Ali Olivo, Attorney-in-Fact	03 Mar 2026	0001582393

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NEO	Common Stock						38,066	01 Mar 2026	Direct
holding	NEO	Common Stock						18,900	01 Mar 2026	Amended and Restated Anthony P. Zook Living Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEO	Stock Option (Right to Buy)	Award	$0	+675,676		$0.000000	675,676	01 Mar 2026	Common Stock	675,676	$10.81	Direct	F1, F2
transaction	NEO	Restricted Stock Unit	Award	$0	+406,918		$0.000000	406,918	01 Mar 2026	Common Stock	406,918	$0.000000	Direct	F3, F4
holding	NEO	Stock Option (Right to Buy)						8,353	01 Mar 2026	Common Stock	8,353	$14.82	Direct
holding	NEO	Stock Option (Right to Buy)						8,672	01 Mar 2026	Common Stock	8,672	$13.71	Direct
holding	NEO	Stock Option (Right to Buy)						729,927	01 Mar 2026	Common Stock	729,927	$10.44	Direct	F5, F6
holding	NEO	Restricted Stock Unit						421,496	01 Mar 2026	Common Stock	421,496	$0.000000	Direct	F4, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%.
F2	On March 1, 2026, Mr. Zook was granted 675,676 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F3	On March 1, 2026, Mr. Zook was granted 406,918 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F4	Once vested, the shares of common stock are not subject to expiration.
F5	This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
F6	On April 1, 2025, Mr. Zook was granted 729,927 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F7	On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.